Correlation Between Enlivex Therapeutics and Pluri

Can any of the company-specific risk be diversified away by investing in both Enlivex Therapeutics and Pluri at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Enlivex Therapeutics and Pluri into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Enlivex Therapeutics and Pluri Inc, you can compare the effects of market volatilities on Enlivex Therapeutics and Pluri and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Enlivex Therapeutics with a short position of Pluri. Check out your portfolio center. Please also check ongoing floating volatility patterns of Enlivex Therapeutics and Pluri.

Diversification Opportunities for Enlivex Therapeutics and Pluri

0.15

Correlation Coefficient

Enlivex Therapeutics  Pluri

Average diversification

The 3 months correlation between Enlivex and Pluri is 0.15. Overlapping area represents the amount of risk that can be diversified away by holding Enlivex Therapeutics and Pluri Inc in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Pluri Inc and Enlivex Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Enlivex Therapeutics are associated (or correlated) with Pluri. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Pluri Inc has no effect on the direction of Enlivex Therapeutics i.e., Enlivex Therapeutics and Pluri go up and down completely randomly.

Pair Corralation between Enlivex Therapeutics and Pluri

Given the investment horizon of 90 days Enlivex Therapeutics is expected to under-perform the Pluri. In addition to that, Enlivex Therapeutics is 1.57 times more volatile than Pluri Inc. It trades about -0.03 of its total potential returns per unit of risk. Pluri Inc is currently generating about 0.03 per unit of volatility. If you would invest  431.00  in Pluri Inc on December 28, 2024 and sell it today you would earn a total of  12.00  from holding Pluri Inc or generate 2.78% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Insignificant
Accuracy	100.0%
Values	Daily Returns

Enlivex Therapeutics  vs.  Pluri Inc

Enlivex Therapeutics

Risk-Adjusted Performance

Very Weak

Over the last 90 days Enlivex Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest weak performance, the Stock's essential indicators remain stable and the latest fuss on Wall Street may also be a sign of long-term gains for the venture sophisticated investors.

Pluri Inc

Risk-Adjusted Performance

Weak

Compared to the overall equity markets, risk-adjusted returns on investments in Pluri Inc are ranked lower than 2 (%) of all global equities and portfolios over the last 90 days. Even with relatively invariable basic indicators, Pluri is not utilizing all of its potentials. The current stock price agitation, may contribute to short-term losses for the retail investors.

Pair Trading with Enlivex Therapeutics and Pluri

The main advantage of trading using opposite Enlivex Therapeutics and Pluri positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Enlivex Therapeutics position performs unexpectedly, Pluri can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Pluri will offset losses from the drop in Pluri's long position.

The idea behind Enlivex Therapeutics and Pluri Inc pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Money Flow Index module to determine momentum by analyzing Money Flow Index and other technical indicators.